As we have previously discussed on this
blog and
elsewhere, the Federal Circuit's decision in Arthrex v.
Smith & Nephew has generated significant discussion and
controversy in the patent world. On December 16, both parties and
the U.S. government asked the full Federal Circuit to reconsider
the panel decision—each advancing distinct arguments in
support of their petitions for rehearing and rehearing en
banc.
To recap, the Arthrex panel held that, in light of the
rights and responsibilities afforded to administrative patent
judges (APJs) under the Patent Act, APJs are "principal
officers" within the meaning of the Appointments Clause of the
U.S. Constitution, thus requiring appointment by the President with
the advice and consent of the Senate. U.S. Const. art. II, §
2, cl. 2; Arthrex, 941 F.3d 1320, 1335 (Fed. Cir. 2019).
Because APJs are appointed by the Secretary of Commerce in
consultation with the Director of the USPTO and not by the
President, the panel held